Peer-influenced content. Sources you trust. No registration required. This is HCN.
GoodRx for Healthcare Professionals
These medications can reduce blood flow through the kidneys, which can contribute to kidney damage or failure. Patients with heart failure, liver disease, or existing kidney problems are at a higher risk.
Clinical Pharmacology November 18th 2025
MedCentral
“This guideline is a tour de force, not just a technical manual. It’s a roadmap for precision, prevention, and equity in hypertension care.” – Ragavendra Baliga, MBBS
Cardiology October 22nd 2025
Mayo Clinic Labs
Most medications are eliminated by the kidneys and appear in urine, enabling objective detection through mass spectrometry that can spur clinical discussions about barriers to medication adherence, absorption issues, and potentially new treatment plans.
Cardiology October 1st 2025
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Compared to those co-prescribed azithromycin, patients receiving clarithromycin had a significantly higher risk of hyperkalemia and AKI. The risk of hyperkalemia increased as kidney function declined.
Cardiology September 3rd 2025
Medical Professionals Reference (MPR)
Similar efficacy was observed in pediatric patients aged 12 years and older – demonstrating consistent treatment benefit across age groups in the pivotal trial.
Internal Medicine August 27th 2025
Clinical Advisor
Nationwide analysis of more than 75,000 patients reveals consistent CKD risk elevation across all age groups and genders, with strongest associations in patients requiring frequent clinical interventions.
Dermatology July 18th 2025